Progress in the study of mefloquine as an antibiotic adjuvant for combination bacterial inhibition treatment

HIGHLIGHTS

  • Who: Xiaofang Liang from the Army Medical University, China have published the research work: Progress in the study of mefloquine as an antibiotic adjuvant for combination bacterial inhibition treatment, in the Journal: (JOURNAL)

SUMMARY

    Antibiotics, among the most important medical discoveries of the 20th century, remain the main anti-infective drugs and have saved countless lives, while improving quality of life for humanity broadly (Cook and Wright, 2022). Despite continuous development and advances in medical science, genetic changes and the widespread and irrational use of antibiotics in healthcare, animal husbandry, and agriculture have . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?